Belvedere Trading »

Revolution Medicines shares owned by Belvedere Trading

Quarter-by-quarter ownership of Revolution Medicines (RVMD) shares owned by Belvedere Trading from 13F filings

Historical chart of Belvedere Trading investment in Revolution Medicines

Tip: Access up to 7 years of quarterly data

All positions including Revolution Medicines held by Belvedere Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revolution Medicines by Belvedere Trading

Quarter filed Position value Share count Share price at filing
2023-09-30 $886k 32k 27.68
2021-09-30 $492k 18k 27.95

More positions owned by Belvedere Trading

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors (TSLA)
Ishares Tr Russell 2000 Etf (IWM)
Meta Platforms Cl A (META)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon Call Option (AMZN)
Spdr Gold Tr Gold Shs (GLD)
Microstrategy Cl A New (MSTR)
Ishares Silver Tr Ishares (SLV)
Kraneshares Tr Global Carb Stra (KRBN)
Global X Fds Global X Uranium Call Option (URA)
Alphabet Cap Stk Cl A (GOOGL)
Carvana Cl A Call Option (CVNA)

View all positions for Belvedere Trading

Top funds holding Revolution Medicines

Wellington Management Company
Vanguard Group
Nextech Invest
BVF
Casdin Capital
Alphabet
Baker Bros. Advisors
Bellevue Group
T. Rowe Price Associates
Jpmorgan Chase & Co
Boxer Capital
Arch Venture Corp
Deerfield Management Company
Holocene Advisors
Henderson Group

View all funds holding Revolution Medicines